Virtual Conference Date: August 18–19, 2021 Social Media Strategies Summit: First Responders is being held on August 18-19, 2021 as a virtual event. First responders, command staff, and social media professionals are invited to join their peers online at the premier social media event for public safety professionals and first responders. The 2-day event will feature 15 curated series of sessions, from influential speakers about diverse topics related to the latest social media strategies and trends. Top reasons to attend:

• Connect with your first response and public safety peers to share experiences, views, and learn new social media strategies.
• The SMSS offers the best networking opportunity to network with agency peers across the country.
• Participate in the live sessions, discussions, gets your queries answered and interact with eminent industry speakers and other attendees.
• Learn the tactics of social media and crisis communications, improving agency reputation, and building relationships with your colleagues, customers, and business associates.
• Monitor, access, and audit your current social media initiative and make improvisations.

The SMSS will start with the opening remarks from the summit emcee thereafter speakers and attendees will have the chance to discuss the best social media practices and management plans. They will also discuss the successful editorial planning for government agencies. This informative session will be particularly useful for businesses and leaders who are in the process of designing a new social media strategy. Attendees will learn the basics and the foundation of a sustainable social media strategy that you can incorporate to train and empower your team. Attendees will get access to:

• 10 live sessions PLUS 4 additional on-demand sessions to watch on your own time
• Access to all presentation videos and slides for a full 6 months post-event
• Live chat and speaker Q&A, 1:1 meetings, and video-chat networking lounge

SMSS is the top online event for first responders and social media marketing professionals who can avail this consolidated platform to hone their marketing skills and gain professional insights into new and emerging influencer marketing tools and strategies. If you would like to participate with colleagues and peers, group discounts are also available. For attendees looking at expanding business opportunities by strengthening their social media initiatives, connect with these 2 days of the social media networking summit. To know more about the details of the event, please visit https://ibn.fm/2Gt3k

• Mr. Greg McKee, CEO of Tryp Therapeutics, appeared on The Dealmaker Podcast to share insights on the company and the psychedelics industry
• During the interview, he discussed the potential of psychedelics in the treatment of PTSD and other mental disorders
• Greg also shared the challenges that the industry is facing currently, mostly to do with legislation
• McKee also shared how people can help the company and the industry by pushing for the decriminalization of psychedelics and taking part in clinical trials

On August 2, 2021, the Dealmaker Podcast posted an interview with Greg McKee, the Chief Executive Officer (“CEO”) of Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF). The show, hosted by Oren Klaff, sought to give the audience an understanding of Tryp Therapeutics’ operations, along with Mr. McKee’s personal story on how he ended up as the CEO of the company (https://ibn.fm/Puuse). It offered some great insights into the future of the psychedelics space, along with what ordinary people can do to take the industry to the next level. When discussing what Tryp Therapeutics is all about, Mr. McKee acknowledged the current boom in the psychedelics space and the potential that these substances hold. He noted: “There are a lot of naturally-derived chemistries around that eventually find their way into more traditional drug development pathways. Psychedelics are some of those.” Mr. McKee mentioned his interaction with former Navy SEALs, all of whom developed Post-Traumatic Stress Disorder (“PTSD”), along with other mental disorders. The patients did not see lasting efficacy on their current and standard of care treatments. Their use of more mainstream forms of therapy and treatment did not seem to work until they tried 5-MeO-DMT, a psychedelic. However, these patients did see an impact after using a psychedelic compound. The success of this psychedelic to these former Navy SEALs gave McKee the reassurance he needed that psychedelics could be of help, not just to former military officers but also to millions of other patients who suffer from chronic pain. However, he noted the most important hindrance along the way, approval. “If we can bring these chemistries to market through an FDA pathway, then we think we can completely change those patients’ lives, along with many, many other kinds of patients that suffer from chronic pain,” he noted (https://ibn.fm/pncrO). Tryp Therapeutics is a pharmaceutical company that develops clinical-stage compounds designed to treat diseases with high unmet medical needs. It seeks to achieve this through accelerated regulatory pathways. The company’s current flagship program involves developing synthetic psilocybin drug candidates to treat chronic pain and eating disorder indications. It regards itself as a pioneer in developing psilocybin-related drugs and hopes to follow the same path as some cannabis pioneers that have made waves and achieved a lot in the past couple of years. The interview showed Mr. McKee’s passion for the job and how much he aligns with his company’s vision. He pointed out that although he is not the founder of the company, he understood the vision that the founder had for the company and the commitment it takes to be the company’s CEO. More importantly, Mr. McKee cited the benefits that come with the use of psilocybin in treating pain. For one, he discussed their effectiveness without the accompanying risk of addiction associated with opioids. He also acknowledged that psychedelics are far from mainstream, but that is an opportunity for the company to play the role of a first-mover. “They (psychedelics) are not mainstream yet. That’s actually the opportunity. Nobody’s done that yet. We’re just now making them synthetically and making them up to pharmaceutical-grade standards,” Mr. McKee noted. McKee noted that FDA approvals take time. However, he pointed out that if anyone wanted to play a role in the industry’s growth and, more specifically, the development of Tryp Therapeutics, they could write to or call their legislators to push for the decriminalization of psychedelics. He also noted that the company welcomes people with any diseases it addresses to participate in their clinical study. This interview offered a glimpse into Tryp Therapeutics operations, the opportunities and challenges within the psychedelics industry. Additionally, it provided insights into Mr. McKee’s ambitions, his vision for the company, along with his informed opinion on the psychedelics industry that is currently experiencing a spike in growth. To listen to the whole podcast episode, please visit https://ibn.fm/avEnz For more information, visit the company’s website at www.TrypTherapeutics.com. NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

• Mind Cure Health Inc. announced Jerry White’s appointment into the company’s advisory board
• Mr. White brings a wealth of experience from his years of powering global movements and working with key leaders and personalities around the world
• MINDCURE forecasts that with Mr. White’s addition to the board, the company will be well-positioned to achieve bigger and better goals, all while working towards its overall vision of building mental wealth globally

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) announced that it has appointed Jerry White as an advisor to the company. Mr. White would be an excellent addition to the company’s advisory board given his expertise, ambition, and track record of the achievements (https://ibn.fm/Fnt3f). In an official statement confirming the appointment, Mr. White reckoned: “I’m thrilled today to be joining MINDCURE as an advisor. The company’s ambition to improve access to mental health through new technologies and psychedelic medicines is timely and vital.” Mr. White has been recognized globally for his efforts in engaging large audiences to power global movements. is a recognized leader of the International Campaign to Ban Landmines and a co-recipient of the 1997 Nobel Peace Prize. He is also known for leading high-impact campaigns, some of which have led to international treaties (https://ibn.fm/kYy7j). Mr. White worked closely with the late Princess Diana, the Princess of Wales, and President Obama, serving as the United States (“US”) Deputy Assistant Secretary of State. Kelsey Ramsden, the President and Chief Executive Officer (“CEO”) of Mind Cure, acknowledged that Mr. White would be a valuable asset to the company’s advisory board. “Never shying away from audacious goals, driving transformational global movements, asking the toughest of questions, and translating them to strategy- this is what Jerry brings and why I am so thrilled to welcome him to the advisory board at MINDCURE. It’s an honor to welcome a truly noble and humane impact strategist to our advisory board,” Mr. Ramsden noted. “I look forward to working with Jerry on our visionary strategy to build mental wealth worldwide,” he added (https://ibn.fm/ro9X3). MINDCURE is a life sciences enterprise that develops digital therapeutics technology. It is also known for researching psychedelic compounds to scale science-based and evidence-backed mental health therapy globally rapidly. With 40% of adults in the United States dealing with mental health issues or substance abuse, psychedelics offer healthier and more promising alternatives for healing (https://ibn.fm/Jftpj). MINDCURE is well-positioned to address this growing problem. With Jerry White’s addition to the advisory board, MINDCURE hopes to achieve bigger and better goals while working towards its overall vision of building mental wealth globally. For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

• SRAX will host 2021 LD Micro Main Event on October 12-14, 2021
• Conference is set to be held in in-person format in Los Angeles as well as virtually, through the Sequire Virtual Events platform
• The conference builds on success from LD Micro Invitational, a three-day microcap conference held between June 8-10, 2021

SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has announced that it will be hosting the 2021 LD Micro Main Event, both in-person in Los Angeles as well as virtually via its Sequire Virtual Events platform, on October 12-14, 2021 (https://ibn.fm/hq6RG). The three-day event will mark a return to an in-person format for the LD Micro Conference after nearly two years, and will seek to combine both physical and virtual elements to provide attendees with a unique and immersive experience. “About time,” commented LD Micro Founder Chris Lahiji. “It has been nearly two years since our last physical conference. I wanted our 14th installation to host all the executives and investors that supported us. I’ll be looking forward to greeting everyone with fist bumps, chest bumps, and hugs.” This year’s LD Micro Main Event will feature approximately 150 companies, each of whom will carry out a 25-minute presentation in both live and virtual formats, catering to the thousands of conference delegates. Investors attending the conference will be able to meet with corporate management teams in a live, one-on-one or small group meeting format to gain further insights as to an individual company’s operational highlights, with investors from around the world able to access each company’s virtual presentation. Boasting a network of over five million influential, forward-thinking investors and shareholders, the Sequire platform has established a robust reputation as a venue where investors can congregate to learn, share, and network on a wide range of industry related topics. The LD Micro Main Event is the latest highlight within an extensive conference series designed by SRAX and Sequire to offer added value to their budding investor community. Sequire had previously played host to the 2021 LD Micro Invitational (https://ibn.fm/oRhW7), a prominent three-day virtual investor conference, held between June 8-10, 2021. In addition to featuring over 190 microcap companies, including the best performing companies from the LD Hall of Fame, the event also played host to a myriad of influential keynote speakers, including the likes of Jaime Rogozinski, Rishi Khanna, Matt Hulsizer, Laurie Segall & Liz Claman. Sequire’s extensive and diverse conference series ranks amongst the various strategies employed by parent Company, SRAX, to augment and streamline their operations over the past few months. Other measures undertaken by the Company include naming entrepreneur and 2020 presidential candidate Brock Pierce to the Company’s board of directors as well as divesting an equity stake in TI Health (formerly known as SRAXmd). As illustrated by the recent LD Micro Invitational conference as well the return to a live, in-person format for the upcoming 2021 LD Micro Main Event, SRAX’s Sequire and LD Micro stand well poised to benefit from their ongoing success amongst corporate issuers, and investors alike. For more information, visit the company’s websites at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Streamlytics helps consumers get paid for their data through its proprietary Data Valuation algorithm
• The company is the largest first-party provider of African American data
• Streamlytics has a patent-pending new data standard, the Universal Data Interchange Format, that powers the company’s data unification
• The global alternative data market was valued at $1.06 billion in 2019 and is expected to grow at a CAGR of 40.1% to reach more than $8 billion by 2027
• The global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to achieve a CAGR of 40.2% from 2021 to 2028
• Streamlytics is a minority-owned, women-led company
• The company’s founder is one of Fast Company’s 100 Most Creative, Inc. Magazine’s Female Founders 100, ADWEEK’s Women Trailblazers, Goldman Sachs 100 Most Intriguing Entrepreneurs, and Business Insiders’ 25 Most Influential African Americans in Technology

Streamlytics provides ethical, people-powered data, spanning millions of data points from today’s fastest growing communities across the United States. The company unlocks the power of actual data usage, reflective of how people create data today – simultaneously across all types of platforms, not by rigid panels or unethical tracking. By partnering with consumers across the nation, the company has gained unparalleled access to audiences’ and shoppers’ content consumption and purchasing patterns across Netflix, Google, Amazon and more. Streamlytics’ first consumer facing data acquisition app allows African American consumers to own their data through a data license, value their data with its proprietary data valuation algorithm, and get fairly paid for their data. The result is ethical data transactions and unmatched insight into the decisions that consumers are making across platforms. The company’s data signals are not limited to purchase and content consumption. The breadth of activity spans fitness, health and universal mobility. The current archaic model of consumer data collection across many industries is to use second- or third-party assumptive data based on cookies or affinities, which has a high margin of error causing an enormous amount of waste in financial resources for client organizations. Streamlytics provides clear, accurate, full-spectrum data, delivering the true picture of a coveted consumer group’s activity across their digital footprint. Since its founding, the company’s mission has been to disrupt the deceptive online data collection processes that have become commonplace. Streamlytics’ drive to prioritize consumer data collection transparency and ethics has led to tremendous growth. The company recently announced it had reached a milestone of more than a quarter-billion data points. Streamlytics’ impressive growth over the past year is largely due to expansion, adding platforms like Apple, Uber, Uber Eats, Postmates and others. The company’s patent-pending data standard, Universal Data Interchange Format (“UDIF”), powers the unification of cross-platform data sources and formats into a single unified data format. Streamlytics leads the industry in consumer data unification, which is increasingly valuable as companies look to navigate away from third-party data solutions and integrate ethical first-party data across corporate strategy, product innovation, artificial intelligence, marketing and more. How it Works Streamlytics unifies consumer data from today’s fastest growing communities across popular platforms spanning over 400 million data points. We ethically unlock the power of actual usage data (directly from the source) and help companies grow by enhancing their 1st-party data strategy across sales, marketing, product, and artificial intelligence. Streamlytics data enhances existing measurement tools by focusing on density. The company’s approach provides a number of benefits over traditional data sourcing platforms, including:

• Multidimensional data that offers visibility into consumption behaviors that define decision drivers for consumers
• An integrated approach that connects a variety of data sources and types to paint the clearest picture of consumer behavior
• A clear understanding of the consumer, allowing for greater targeting precision that directly impacts the effectiveness of campaigns
• Ethical sourcing, with consumers directly compensated for their data
• Protection of all personal identifying information (“PII”) to ensure privacy and security

The company sells data that has been ethically sourced through a Standard Datastream (a streamlined feed consisting of roughly 22.5 million data points) and a Custom Datastream (a full spectrum feed spanning over 150 million data points). Client organizations subscribe to either datastream, based on the specific audiences they want to reach. Organizations most often use Streamlytics data to enhance their first party data strategies in an effort to increase revenue and sales, refine corporate strategy and enhance machine learning training data to reduce algorithmic bias. Market Outlook The global alternative data market was valued at $1.06 billion in 2019 and is expected to grow at a CAGR of 40.1% to reach more than $8 billion by 2027. The global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to achieve a CAGR of 40.2% from 2021 to 2028, according to data from Grand View Research. Streamlytics believes a new market space is emerging at the intersection of these two thriving industries called ‘Community Driven Data’, which will comprise consumers who have opted in to share their data, and companies that decide using ethically sourced data is better than fines and negative media coverage they could get from continuing to do it the old way. Streamlytics has positioned itself as the leader of this emerging new market space as consumers increasingly opt out of sharing their data under the current model, and as new laws – like Prop 24, the California Consumer Personal Information initiative passed overwhelmingly by voters in 2020 – mandate greater privacy protections for, and limits on corporate use of, consumer data. Management Team Angela Benton is founder and CEO of Streamlytics. She is a pioneer of diversity in the technology industry and of raising awareness around the inequalities that exist in the industry. In 2011, she founded NewME, the first entrepreneurial accelerator globally for minorities. Through her leadership, NewME has accelerated hundreds of entrepreneurs, helping the nascent companies to raise more than $47 million in venture capital funding. That company was acquired in 2018. Arisha Smith is the Chief Revenue Officer of Streamlytics. An innovator in advertising technology, she has designed growth strategies for businesses leveraging digital, social and mobile platforms for over 20 years. She has held marketing positions at Accenture and Microsoft, as well as at Vibe Media. She earned an MBA from Florida A&M University. For more information, visit the company’s website at www.Streamlytics.co. NOTE TO INVESTORS: The latest news and updates relating to Streamlytics are available in the company’s newsroom at https://ibn.fm/Stream

• Friendable’s 120-day strategy is underway and encompasses several milestones, including the launch of a redesigned Fan Pass platform and new website for its core business
• The company recently announced it had completed several rebranding initiatives, including an updated corporate deck and new website for its Fan Pass livestream platform
• The rebranding comes on the heels of the launch of Fan Pass 2.0 and a recent SmallCapVoice.com interview in which Friendable CEO Robert A. Rositano Jr. discussed the company’s vision, progress so far, market opportunity, the new version of its Fan Pass platform, and revenue and growth strategy

In a bid to continue building value in the live event coordination and livestreaming business, mobile technology and marketing company Friendable (OTC: FDBL) formulated a 120-day strategy encompassing several key milestones. These included a new company/corporate website, transitioning focus entirely to the Fan Pass platform, completing beta testing for the mobile and web application, new tools for artists, new mobile and web app deployment, and more (https://ibn.fm/07qhn). Having launched version 2.0 of the Fan Pass platform, the company set the wheels in motion for the attainment of the other milestones. In a recent announcement, the company moved closer to fulfilling its 120-day strategy by announcing it had completed several rebranding initiatives, including an updated corporate look and a new website for its Fan Pass livestream platform (https://ibn.fm/RnBeU). View the new websites, messaging, and branding at www.FanPassLive.com and www.Friendable.com. The rebranding – which sets the foundation for Friendable’s next phase of growth, with the company anticipating to kick off several important growth initiatives in the coming weeks – is intended to enable FDBL to clearly communicate who it is and what it does as it focuses on building a big business in the rapidly growing marketplace as well as prepare to ramp up advertising efforts for both artist and fan acquisitions. It also represents a shift from the company’s initial, successful focus on raising awareness of the Fan Pass brand throughout the last year. “The success of this campaign led to faster-than-expected growth in terms of user sign-ups, and we quickly moved to accomplish two ancillary goals: 1. Support the platform through cohesive message, business model and strategy; 2. Adjust the development of version 2.0 to deliver a superior platform to artists and fans,” commented Friendable CEO Robert A. Rositano Jr. The rebranding announcement comes on the heels of a recent SmallCapVoice.com interview, wherein Robert discussed the company’s vision and plans, revenue and growth strategy, and market opportunities (https://ibn.fm/CuUpF). In describing the Fan Pass platform, Robert noted that the platform – which is all about the artist, discovering new music, and connecting artists with their fans – has enabled artists to earn, perform virtually, create and sell merchandise, and invite their fans to join the platform. “We are bringing to the table a mass-market opportunity for the up-and-coming artist and, really, artists at every level and wrapping them with a support system that will boost them, help acquire and add to their fanbase, and, more importantly, really monetize in the days of uncertainty when venues have been shut down for so long,” Robert stated (https://ibn.fm/VxVri). Robert also allayed concerns brought about by the vaccine-led reopening of the events industry by stating that Fan Pass will still provide backstage access, both live and on-demand, to fans who may not be able to attend live events and concerts due to geographical and financial constraints. “So, we have additional components that we will be stacking up to the business model as the live events and venues open back up,” Robert continued. Robert further explained that Fan Pass version 2.0 has captured everything the company has learned so far, featuring a complete rebuild of UI/UX and how artists and fans interact, and has added new features and ways of developing revenue streams for the artists. Friendable has uplifted various aspects of the Fan Pass platform to tailor it to what artists are asking for and what fans want to see. The new version also represents the company’s ability to scale. “Over the next 90 days following our V2 release, we are going to start communicating with the market, our shareholders, and the community of partners that we have, and showing how these metrics are stacking and growing and how our revenues are converting and growing. And that 90-day period is going to be the metric that we need for the next 12, 24, and 36 months of revenue projections and growth,” Rositano concluded. For more information, visit the company’s website at www.Friendable.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• FingerMotion is planning to host a corporate update call on August 25 at 1 pm Eastern Time
• As part of the call, FNGR CEO Martin Shen is expected to cover recent developments, including the quarterly financial results, application to uplist to the NASDAQ, and plans for an upcoming annual meeting of shareholders
• A question-and-answer session is scheduled at the end of the call

FingerMotion (OTCQX: FNGR), an evolving technology company with core competency in mobile payment solutions in China, as well as SMS/MMS, will be hosting a corporate update call scheduled for August 25, 2021, at 1 pm Eastern Time. As part of the call, CEO Martin Shen will cover various subjects (https://ibn.fm/PEYuN). The update is planned against the backdrop of recent positive announcements, including the company’s release of Q1 2021 results, in which it reported record quarterly revenue of $6 million. FingerMotion’s SMS & MMS and Telecommunications Products & Services (“TPS”) notched impressive double-digit and triple-digit revenue growth rates, respectively, compared to Q1 2020. Q1 2021 was also the second consecutive quarter in which the company reported revenue from its Big Data division (https://ibn.fm/Kt5QF). During the update call, these results are expected to take center stage along with the company’s recent application to have shares of its common stock listed on the Nasdaq Capital Market. While there is no guarantee that the submission will be approved, the application still marks a key milestone for the company’s evolution, according to Shen (https://ibn.fm/NYG82). Shen is expected to talk about this application, as well as the plans for an upcoming annual meeting of shareholders in the near future. A question-and-answer session, wherein the company will answer questions submitted via emails, is scheduled at the end of the call. More details on this will be provided closer to the day of the call. Founded in 2016, FingerMotion has evolved over the years. It currently has three operational and revenue-generating business units – TPS, SMS & MMS, and Big Data – with plans to make a fourth division, the rich communication services (“RCS”), operational in due course. FingerMotion is one of only a few companies in China with access to wholesale rechargeable minutes from China’s largest mobile phone providers that can be resold to consumers. Additionally, earlier this year, buoyed by its big data product dubbed Sapientus, the company forayed into insurtech through its partnership with Pacific Life Re-insurance, which appears to have set the foundation for similar alliances in the insurtech sector. Since then, FNGR has entered into an agreement with Happy Life Insurance to create an innovative, data-driven insurance business model and also expects additional contracts relating to its insurtech products by the year’s end, To support its foray into insurtech, FingerMotion recently announced the completion of the first stage of prototyping of its insurtech model and expects completion by the end of 2021 (https://ibn.fm/5GR6B) For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Clinical study HYPER-H21-1 evaluates the use of patented DehydraTECH(TM)-processed CBD for use against hypertension
• Hypertension is a primary or contributing factor in the death of almost 500,000 people per year, with approximately one in four adults aged 20 to 44 suffering from high blood pressure
• Initial results of the study show that blood pressure was reduced in both male and female volunteers, resulting in the reinforcement of pre-existing findings demonstrating that DehydraTECH delivers superior performance
• Lexaria plans on launching two additional clinical trials, for a total of three clinical trials in 2021 for the DehydraTECH-CBD with hypertension applications

Lexaria (NASDAQ: LEXX), a global innovator of proprietary patented drug delivery platform DehydraTECH(TM), has released partial results from human clinical study HYPER-H21-1. The study evaluates DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension (https://ibn.fm/4hiM1). Hypertension, also referred to as high blood pressure, is a primary or contributing factor in the deaths of almost 500,000 people per year. Hypertension can double the risk of having a heart attack or quadruple the chance of having a stroke. The likelihood of heart failure, vision loss, renal disease, peripheral artery disease, dementia, and more can be attributed to cases of high blood pressure. Statistically, one in four adults aged 20 to 44 has high blood pressure. The partial results showed that blood pressure was reduced across both male and female volunteers; it was most pronounced with DehydraTECH-CBD in the study’s first 10 to 50 minutes. These results reinforced the pre-existing findings demonstrating that DehydraTECH delivers superior performance over generic CBD controls. Chris Bunka, CEO of Lexaria, commented on the study, saying, “We are very encouraged by these early results in our 2021 hypertension program. Lexaria’s technology enabled a rapid and sustained drop in blood pressure, especially systolic pressure and particularly in Stage 2 hypertensive volunteers.” Lexaria’s DehydraTECH technology is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. The method increases the effectiveness and improves the way that active pharmaceutical ingredients enter the bloodstream (like CBD). Benefits of the delivery method include:

• Quicker delivery
• Increase in bioavailability
• Increase in the brain absorption
• Improved drug potency
• Reduced drug administration cost
• Masked unwanted taste

Lexaria has demonstrated these benefits from other animal studies, elevating the quantity of the drug delivered across the blood-brain barrier by as much as 1,900%. Lexaria was also pleased that the subjects of this human clinical study tolerated the DehydraTECH-CBD, with no serious adverse events or side effects observed or reported. The concentration-matched, generic CBD control ingested resulted in unwanted side effects in some volunteers — primarily gastrointestinal problems, including diarrhea. Lexaria plans to complete its ongoing additional sample and data analyses work for this study, reporting upon those outcomes when complete. A second human clinical hypertension study, HYPER-H21-2, has completed dosing, with three different doses of DehydraTECH-CBD (150mg per dose), administered evenly over the course of a 24-hour monitoring period. The company is optimistic that repeated dosing over this sustained period may further enhance efficacy. The results of both studies will be evaluated and considered before the company begins its planned third human clinical hypertension study planned for fall 2021. Lexaria is considering evaluations for a fourth, expanded, randomized, controlled human clinical hypertension trial. The fourth trial will be dependent on the results from the current trials and investigations into a larger population for a more enhanced statistical and clinical significance. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• PlantX Life is becoming a one-stop shop solution for fans of plant-based foods and other products
• The company has expanded its plant-based meal delivery service in Canada and has launched a similar food-delivery service across Southern California
• PlantX Life also recently announced year-end financials after nearly a year-and-a-half since its incorporation, showing gross revenue of $6.58 million as of March 31
• To help the company meet strategic growth goals, PlantX Life has restructured its administration, naming former CFO Lorne Rapkin as the new CEO and former CEO Julia Frank as the new COO

A British Columbia, Canada-based company with the potential to become an Amazon-like retailer for the plant-sustained community is reporting its continued growth in the United States and in its revenue stream. PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently noted the launch of its XFood plant-based meal delivery service in the United States, as well as its year-end financial results and a restructuring of its leadership. PlantX Life’s platform presents itself as the one-stop shop for everything plant-based, with more than 5,000 plant-based products and plans to expand its product lines from meal and indoor plant deliveries to cosmetics, clothing and its own water brand via e-commerce and brick-and-mortar stores. PlantX has stated its flagship physical store locations will be in Squamish, British Columbia; San Diego, California; and Tel Aviv in the state of Israel (https://ibn.fm/VG8AV). The company announced July 28 that it is launching its XFood delivery service in Southern California, utilizing a ghost kitchen in central Los Angeles as part of an operation similar to food delivery services it is offering in Canada. The company’s San Diego store will open in September and PlantX expects to eventually expand its food delivery services across the United States. “It has long been a dream of ours to be able to deliver food outside of the restaurant setting and in a more personal and personalized way,” PlantX Chief Culinary Officer Matthew Kenney stated in the news release (https://ibn.fm/x3gx9). Kenney added that the three-day meal kits for vegan recipes he has designed and curated “are a representation of how we can build a future where healthy, high-quality food is available to everyone on a daily basis” and that his team’s weekly meal plans reflect the “utmost in health, purity, and of course, pleasure.” PlantX reported July 30 that its year-end (“YE”) financial outlook shows gross revenue of $6.58 million as of March 31, compared with $1,349 for the previous YE statement that reflected the company’s first five months since its Oct. 11, 2019 incorporation, with a gross margin of 21 percent (https://ibn.fm/9Eac6). Its Q4 gross revenue grew 134 percent over Q3, according to the report, with a gross margin of 23 percent in Q4 compared with 20 percent in Q3. “PlantX has been growing its revenue each quarter. We are attributing this to the Company’s investments in operational activities designed to strategically support PlantX’s growth plan,” company founder Sean Dollinger stated as part of the news release. “We are thoroughly focused on six key pillars to ensure the success of our growth strategy: marketing activities, boosting product and service diversity, supply chain expansion, geographic expansion and completing strategic acquisitions.” In order to continue advancing the company toward fulfillment of its goals, PlantX announced Aug. 4 that it is restructuring its administrative operations, with former CEO Julia Frank becoming the chief operating officer and former CFO Lorne Rapkin taking over her place as CEO. Director of Finance Shariq Khan will succeed Rapkin as the new CFO (https://ibn.fm/Uv6uQ). Other corporate news includes the announcements that PlantX has completed its integration as a seller on Walmart Canada Marketplace and Hudson’s Bay Marketplace, that cold-pressed juices maker Little West, LLC, has completed its integration as a subsidiary in the company’s operational structures, and that Khan has been granted 50,000 restricted share units for the term of a year. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• SRAX updates Sequire investor analytics platform with Investment Advisor Feature that allows users to find investment advisor contact information
• Replays from the 2021 Sequire Blockchain Conference now available on demand for next three months
• Blockchain Conference featured 10+ leading blockchain and cryptocurrency companies, keynote presentations from industry experts

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, just upgraded the user experience with a new Investment Advisor Feature (https://ibn.fm/SM6Pr) and on-demand presentation replays from the Sequire Blockchain Conference (https://ibn.fm/blbPW). “This conference was one of the best we’ve ever put on. The content was educational and the companies that presented are paving the way for a crypto future,” said SRAX CEO and Founder Christopher Miglino. “If you have not already watched the presentations and want to be educated on what companies are doing in the space, I would encourage you to view these amazing panels and presentations.” Along with company presentations, the conference featured keynotes by prominent thought leaders and industry royalty, including Brock Pierce, Maja Vujinovic, Saum Noursalehi, Rachel Wolfson, George Stella, Brittany Kaiser, Gilbert Hill Justin Newton, Adrian Baschuk, Bryan Bullett, Fred Thiel and Ibrahim AlHusseini. SRAX has made all the company replays and exclusive keynotes available for the next three months. The panels include topics such as stable coin viability, innovations in mining, industry sustainability, and data privacy. The conference was hosted on Sequire, SRAX’s investor analytics platform. With its unique suite of tools, Sequire helps public companies unlock the power of investor trading insights with metrics that include trading data, current share price, volume change, % change, and more. As the popularity of Sequire continues to soar, SRAX keeps adding new features – such as the recently released Investment Advisor Feature that provides contact information and filtering capabilities that enable users to create groups for targeted communications. “Registered Investment Advisors have been the largest investors in our company SRAX and have been a significant part of the growth of our shareholder base. We are now providing the tools that will enable issuers to identify, communicate with and track the progress of specific advisors,” said Miglino. “Issuers can use this new feature to organize in-person events in specific geographic areas or launch virtual events on the Sequire Audience platform. Once you identify the prospective candidates, the Sequire CRM can help track the progress with a specific advisor.” Since its creation in 2019, Sequire has grown to over five million active retail investors across 180+ companies (https://ibn.fm/VWnIU). With its unique suite of tools, Sequire helps companies track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. To view the presentations and keynotes from the 2021 Sequire Blockchain Conference visit https://blockchain21.mysequire.com. For more information, visit the company’s websites at www.SRAX.com and www.MySequire.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX